Background {#Sec1}
==========

Dengue infection is a rapidly re-emerging mosquito-borne infectious disease caused by dengue virus (DENV), that affects approximately 390 million people annually \[[@CR1]\]. More than 100 countries, spanning from the Americas, the Western Pacific, South-East Asia, and Africa to Europe, have reported severe epidemics of dengue. In fact, more than 3.9 billion people worldwide are estimated to be at transmission risk \[[@CR2]\]. Dengue infections cause varying degrees of dengue disease, with major clinical manifestations ranging from asymptomatic Dengue Fever (DF) to serious Dengue hemorrhagic fever (DHF) and Dengue shock syndrome (DSS) \[[@CR3]\]. Unfortunately, approximately 50--100 million DF cases and hundreds of thousands of DHF cases occur annually \[[@CR4], [@CR5]\]. Since there are still no licensed vaccines or specific antiviral drugs, and since each patient with dengue hemorrhagic fever needs to face exorbitant medical costs, dengue infections have become a serious global health problem, and a heavy socioeconomic burden affecting healthcare systems worldwide.

As the etiologic agent of dengue fever, DENV belongs to the genus *Flavivirus* and family *Flaviviridae* \[[@CR6], [@CR7]\] primarily transmitted by *Aedes aegyptis* and *Aedes albopictus* \[[@CR8], [@CR9]\], that are known to circulate in the tropical and subtropical regions of the world \[[@CR8]\]. DENV is an enveloped, positive-sense, single-stranded RNA virus. The genome of DENV is approximately 11 kb in length, with one open reading frame (ORF) flanked by 5′ and 3′ non-coding regions. A polyprotein is encoded by the ORF, which is cleaved into three structural proteins: C: Capsid glycoprotein; M: membrane glycoprotein; E: envelope glycoprotein; and seven non-structural proteins (NS): NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 \[[@CR10]\]. Furthermore, DENV is divided into four serotypes(DENV- 1 to DENV-4)based on antigen cross-reactivity. Since there is no cross protection among serotypes, secondary infection of heterologous DENV serotypes often results in severe disease \[[@CR11]\]. In addition, each serotype is further divided into distinct genotypes based on viral genome sequencing and evolutionary analysis \[[@CR12]\].

Over the past decade, dengue infection has expanded over the vast geographical range \[[@CR13]--[@CR16]\], This may be caused by more frequent international travel, climate change, virus evolution, unplanned urbanization, globalization, population mobility and failure of Aedes mosquitoes control \[[@CR13], [@CR14], [@CR17], [@CR18]\]. In Mainland China, the first recorded DENV infection occurred in Guangdong in 1978 \[[@CR19]\]. Over the past 30 years, DENV has spread throughout the country. Although the four serotypes have been circulating in Guangdong, Guangxi, Hainan, Fujian, Zhejiang and Yunnan provinces of China \[[@CR20], [@CR21]\], the DENV-1 has been a predominate serotype since 1990s \[[@CR21]\]. Geographically, provinces such as Guangdong, Guangxi, Hainan, Fujian, and Zhejiang are situated in the southeast coast of China, whereas Yunnan borders with Southeast Asian countries, such as Myanmar, Laos, Thailand, Vietnam which are all considered endemic risk areas \[[@CR21]--[@CR25]\]. The spread of DENV by tourists returning from Southeast countries is common in China, especially in Yunnan Province. Since 2000, most of the DF documented in Yunnan have been sporadic imported cases. In 2013, a large-scale DENV-3 outbreak comprising 1287 indigenous cases and 44 imported cases occurred in Xishuangbanna, Jinghong, Yunnan \[[@CR26]\]. Epidemiological analysis showed that this outbreak was closely related with the imported dengue cases from Laos and Myanmar \[[@CR26], [@CR27]\], which suggested that imported dengue cases were mainly responsible for outbreaks and the circulation of DENV-3 in Yunnan, China. Due to the special geographical location, humid climate, booming international tourism, population mobility and the spread of the Aedes mosquitoes, Yunnan is at risk of becoming an endemic risk area in the future.

Although dengue cases imported from Laos have been reported in previous studies, they mainly focused on the envelope (E) gene of the imported DENV-3. The complete genome sequence and molecular characterization of the DENV-3 strain imported from Laos are still not available. In the current research, we reported the complete genome sequence and genomic characterization of a DENV-3 strain imported from Laos. The results from this study provide valuable clues for disease surveillance, transmission control and vaccine design.

Methods {#Sec2}
=======

Source of virus {#Sec3}
---------------

A 10 year old student, who resides in Pu'er, Yunnan Province, China, went on a 7 day trip to Laos from August 10th to August 16th, 2013. She experienced slight fever during the 4th day of the trip, and influenza like symptoms on the third day after returning home. In August 20th, 2013, clinical diagnosis showed a positive result for NS1 antigen of patient's serum based on the viral NS1 antigen colloidal gold test using the Dengue Ag Rapid Test (CTK Biotech, Inc., San Diego, CA), in the Jinghong People's Hospital in China. The medical history of the patient was unremarkable with dengue fever and other flaviviruses disease. Written informed consent was obtained from this patient and her legal guardian. A serum sample was collected from the patient within 3--7 days after the onset of the illness and stored in −80 °C until use.

Virus isolation and serotyping {#Sec4}
------------------------------

The patient's serum was inoculated into the C6/36 *Aedes albopictus* cell line in RPMI 1640 medium (Biological Industries, USA) supplemented with 2% fetal bovine serum (Biological Industries, USA) at 28 °C in 5% CO2. When 70% cytopathic effect (CPE) was observed, the virus was passaged twice more to prepare viral stocks. Supernatant from infected cells was harvested and stored at −80 °C until used. Viral RNA was extracted from 500 μL of infected culture supernatant by Trizol reagent (Tiangen, Beijing, China) according to the manufacturer's instructions. For virus identification, reverse transcriptase polymerase chain reaction (RT-PCR) amplification was carried out as previously described \[[@CR28]\]. Briefly, viral RNA was reverse transcribed in a BioRad C1000 Cycler system using GoScript™ Reverse Transcription System (Promega, WI, USA) according to the manufacturer's instructions. The cDNA was used for PCR analysis. Five pairs of primers, which were designated as universal primers D1 and D2 of DENV, and four typing primers D1 and TS1 of DENV-1, D1 and TS2 of DENV-2, D1 and TS3 of DENV-3, D1 and TS4 of DENV-4 (primers were described in Additional file [1](#MOESM1){ref-type="media"}: Table S1), were employed to amplify the partial capsid/membrane glycoprotein precursor (PrM) gene of DENV. PCR amplification was conducted with the following program: 2 min at 94 °C, followed by 35 cycles at 94 °C for 30 s, 55 °C for 30 s, 72 °C for 1 min, and a final extension step at 72 °C for 10 min. The specific PCR amplicons were further confirmed by agarose gel electrophoresis. PCR products were visualized by a biospectrum® 815 imaging system (UVP, USA).

Genome amplification and sequencing {#Sec5}
-----------------------------------

A total of nine overlapping sub-genomic fragments that spanned the complete genomic region were amplified using nine pairs of primers (Additional file [2](#MOESM2){ref-type="media"}: Table S2) \[[@CR29]\] by RT-PCR. First, viral RNA was reverse transcribed using the GoScript Reverse Transcription System (Promega, WI, USA) following the manufacturer's instructions. The RT reaction was conducted under the following conditions: 25 °C for 5 min, followed by 1 h at 42 °C, then 72 °C for 15 min. Next, the PCR was carried out in a reaction mixture of 50 μL containing 5 μL of 10 × La Taq Buffer (Mg^2+^ Plus), 8 μL of dNTP mixture (2.5 mM), 2 μM of forward and backward primers, and one unit of high fidelity La Taq DNA polymerase (TaKaRa, Dalian, China). PCR amplification was performed under the following parameters \[[@CR29]\]: 94 °C for 5 min, followed by 35 cycles of denaturation at 94 °C for 30 s, annealing at 55 °C for 30 s, extension at 72 °C for 2 min and final extension at 72 °C for 5 min. The PCR results were analyzed by 1% agarose gel electrophoresis and visualized by a biospectrum® 815 imaging system (UVP, USA). Finally, the PCR products were used as templates for bi-directional DNA sequencing by the Sanger dideoxy sequencing method (Invitrogen Ltd., Shanghai).

Genomic characterization and sequencing analysis {#Sec6}
------------------------------------------------

The sequences of nine sub-genomic fragments were assembled into a complete genome by removing overlapping sequences with the DNAMAN software program (v. 8.0.8.789) (Lynnon Biosoft, USA). The assembled viral genome was further aligned by NCBI-BLAST (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>) to determine the similarity with other virus strains. Multiple sequences alignment analyses of nucleotides and amino acids for six closely related DENV-3 isolates from China, Laos and other countries were performed based on MegAlign module of Lasergene 7 software package DNASTAR (DNASTAR Inc., USA). Further, the secondary structure of 3′ UTR and 5′ UTR of the YNPE3 strain and prototype strain H87 (M93130) of DENV-3 were determined by the MFOLD software package (<http://unafold.rna.albany.edu/?q=mfold>) \[[@CR30]\] using default folding parameters.

Phylogenetic analysis {#Sec7}
---------------------

Two phylogenetic trees were drawn based on the complete coding sequence (CDS) and E gene of DENV-3. For the E gene, a total of 76 representative strains isolated from different geographical regions in different years were retrieved from GenBank (Additional file [3](#MOESM3){ref-type="media"}: Table S3). For the CDS, a total of 75 representative DENV-3 isolates were prepared (Additional file [4](#MOESM4){ref-type="media"}: Table S4), the two sets of strains were different with a 10% overlap. The evolutionary history was inferred using the Maximum-Likelihood method \[[@CR31]\] of MEGA software (version 7) \[[@CR32]\], with a bootstrap test (1000 replicates) \[[@CR33]\]. The evolutionary distance was calculated using the Tamura-Nei model \[[@CR34]\]. The mutation rate at each site was modeled with a gamma distribution (shape parameter =5). DENV-1 strain Hawaii, DENV-2 strain New Guinea C and DENV-4 strain H241 served as outgroups.

Results {#Sec8}
=======

Identification and serotyping of virus {#Sec9}
--------------------------------------

In order to isolate the virus, the patient's serum was inoculated in cells of the C6/36 cell line until the occurrence of typical CPE, followed by passage twice to increase virus stocks. Compared with normal cells, a typical CPE with the fusion, shedding, aggregation, breaking and suspension were observed in infected cells after 9 days of infection. Furthermore, two fragments with 511 and 290 bp were amplified specifically by RT-PCR with universal primes for DENV and typing primes for DENV-3 respectively, and no specific amplification appeared in the D1TS1, D1TS2 and D1TS4, indicating that the isolate belonged to the serotype 3 of DENV (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Electrophoresis of typical primer identification of DENV-3. The symbol M indicates DL 2000 DNA marker; The D1D2 indicates the universal amplicon that amplified the partial capsid/premembrane gene (511 bp) of DENV by upstream primer D1 and downstream primer D2. The D1TS1 (482 bp), D1TS2 (119 bp), D1TS3 (290 bp) and D1TS4 (392 bp) are specific amplicons of DENV-1, DENV-2, DENV-3 and DENV-4, respectively

Complete genome sequence and genomic characterization of YNPE3 {#Sec10}
--------------------------------------------------------------

To amplify the complete genome sequence of the YNPE3 strain, nine sets of primers were designed to amplify nine overlapping fragments across the whole viral genome. As shown in Fig. [2](#Fig2){ref-type="fig"}, the nine overlapping fragments were amplified specifically by RT-PCR. Moreover, the sequences of all the overlapping amplicons assembly revealed a full-length genome with 10,627 nts for the YNPE3 strain. The complete genome sequence was submitted to the GenBank database under the accession number MF370226.1. The YNPE3 strain contained a single ORF that encoded 3390 amino acids (aa) flanked by 5′ UTR (55 nts) and 3′ UTR (399 nts). The nucleotide acid composition of the YNPE3 strain was 32.11% A, 26.03% G, 21.28% T and 20.58% C. The percentage of purine (58.14%) was higher than that of pyrimidine (41.86%).Fig. 2Electrophoresis of the whole genome sequence amplification from YNPE3 strain on a 1% agarose gel. The symbol M indicates DL 2000 DNA marker; and then from left to right the primer sets are: F1:3F1/3R1, F2: 3F2/3R2, F3: 3F3/3R3, F4: 3F4/3R4, F5: 3F5/3R5, F6: 3F6/3R6, F7: 3F7/3R7, F8: 3F8/3R8, F9: 3F9/3R9

Further similarity analysis by BLAST showed that the YNPE3 strain had the highest identity with the SG(EHI)D3/15095Y15 strain (KY921907) isolated from Singapore in 2015, it possessed 99.4% nucleotide identity and 99.6% amino acid identity. Followed by three strains from Indian (JQ922556, KU216209, KU216208), they showed to share 98.6--98.8% nucleotide identity with YNPE3 strain. Compared with the prototype strain H87, there was 94.0% nucleotide identity and 97.8% amino acid identity. The strains from Laos (KY849769, KY849770, KY849771, KY849772, KY849773, KY849774 and KY849775) shared 93.1% nucleotide identity and 97.8--97.9% amino acid identity with YNPE3 strain. Yet, the strains from China YN01 (KF824902) and YN02 (KF824903) isolated from Yunnan in 2013, shared 92.9% nucleotide identity and 97.7--97.8% amino acid identity.

Moreover, two fragments of about 40 nts, including 1-AGTTGTTAGTCTACGTGGACCGACAAGAACAGTTTCGAC-39 for 5′ UTR and 389-ACGCCAGAAAATGGAATGGTG CTGTTGAATCAACAGGTTCT-429 for 3′ UTR were deleted from the YNPE3 strain, and 11 nts 9-ACGCAGGAAGT-19 insertion presented in the hyper-variable region of the 3′ UTR of the YNPE3 strain when compared with strain H87. In view of the important role of the 3′ and 5′ UTR of Flaviviruses in viral replication and pathogenesis \[[@CR35], [@CR36]\], we analyzed the RNA secondary structures of the 3′ and 5′ UTR of the YNPE3 strain by MFOLD software that was used to predict RNA secondary structures. The results showed that two stem-loops were observed in the 5′ UTR of the YNPE3 and strain H87 (Fig. [3a](#Fig3){ref-type="fig"}). However, due to the deletion of 39 nts in the 5′ UTR of the YNPE3 strain, the large stem loop showed a truncated secondary structure. In addition, the secondary structure in variable region (VR) of the 3′ UTR of the YNPE3 strain was significantly different from that of the prototype H87 strain, the strain YNPE3 presented a unique secondary structure (Fig. [3b](#Fig3){ref-type="fig"}). As show in Fig. [3c](#Fig3){ref-type="fig"}, the overall secondary structure of 3′ UTR of the YNPE3 strain was consistent with H87; only at the terminal part it presented a distinctive structure due to the nucleotides deletions and insertions.Fig. 3Prediction of secondary structure of 5′ UTR and 3′ UTR of strain YNPE3 and compared with the standard strain H87. **a** Prediction secondary structure of the whole 5′ UTR from the YNPE3 strain (nucleotides 1 to 55) and the prototype strain H87 (nucleotides 1 to 94). **b** Prediction secondary structure of the 3′ UTR variable region from the YNPE3 strain (nucleotides 1 to115) and strain H87 (nucleotides 1 to 104). **c** prediction secondary structure of the whole 3′ UTR from the prototype strain H87 and the YNPE3 strain

Amino acid substitution analysis of YNPE3 {#Sec11}
-----------------------------------------

To determine the variations of the amino acids of the YNPE3 strain, the complete amino acid sequences of eight closely related reference strains were retrieved from GenBank database (<http://www.ncbi.nlm.nih.gov>). They were subjected to multiple sequence alignment analysis. As shown in Table [1](#Tab1){ref-type="table"}, compared with strain H87, a total of 75 amino acid substitutions were found in the whole polyprotein of the YNPE3 strain with a substitution rate of 2.2%. These substitutions occurred mainly in the E, NS1, NS3 and NS5 proteins of YNPE3. However, the PrM/M protein was relatively conserved, and there were no amino acid substitutions found. Also, less amino acids substitutions were found in the capsid, NS2B and NS4A proteins of YNPE3. Compared with strain H87, many of the amino acid substitutions in the YNPE3 strain were conservative, and they mainly consisted of exchange of amino acids with similar physicochemical properties; Whereas, few amino acids mutations were involved in changes in polarity, such as E~169:~ A(Ala) → T(Thr), E~301:~ L(Leu) → T(Thr), NS1~93:~ I(Ile) → T(Thr) and NS5~188:~ T(Thr) → A(Ala). Moreover, the strain YNPE3 and Balotra87-s shared the same unique amino acid replacements in some sites.Table 1The major amino acid substitutions among the seven related strains of DENV-3 from China, Laos, India and Singapore as compared with the standard strain H87Aa positionH87YNPE3Balotra87_sYN01UI17760D3/SG/CT7/2012Philippines 1956China 2013India 2013China 2013Laos 2010Singapore 2012GVGIIIGIIIGIIGIIGIORFProteinCapsid 3535RKK 8686KR 108108MIIEnvelope 36181IVVT 404124SLPL 412132HYY 420140ITT 434154EDD 444164SPPPP 449169ATTVVP 505225KEEEEV 550270TNNNNE 551271TSSSST 572292KEEEES 581301LTTE 663383KNNS 671391RKKKK 727447SGGK 732452IVVNS1 82047RK 82148VLLLLL 85683DNNNNN 86693ITT 86794TIIIII 87198ED 893120LKKKKK 912139SNNNNN 951178LMMTTL 961188VII 990217LFF 1029256HYYY 1061288STTTTT 1112339NSSNS2A 116237LFF 1225100EK 1237112ATTTTT 1240115RQQQQQ 1267142TI 1275150VII 1300175IVVVVNS3 150431FLL 1588115ITT 1829356VAA 1865392DEE 1910437DE 1925452VAAAA 1949476MTTTT 1962489WE 1964491EQ 1965492AE 2041568EQQNS4A 216270LI 219199DEE 2192100VIII 2240148VIINS4B 2357115VII 2393151MIINS5 254050ITTTT 2678188TAAA 2778288SNN 2912422RKK 3052562QLL 3075585KTT 3109619IVV 3129639LPP 3130640EGA 3253763TSSSS 3325835DNN 3354864LSPThe GI, GII, GIII and GV represent genotype I, genotype II, genotype III and genotype V, respectively. The accession number of those related strains: H87(M93130), Balotra87_s(KU216209), YN01(KF824902), UI17760(KY849769), D3/SG/CT7/2012(KX380839). YNPE3(MF370226)

Phylogenetic analysis {#Sec12}
---------------------

To determine the evolutionary history of the YNPE3 strain, two phylogenetic trees were drawn based on the E gene and the CDS of DENV-3. The phylogenetic tree based on the E gene revealed that DENV-3 strains had five distinct genotypic groups (Fig. [4](#Fig4){ref-type="fig"}). The YNPE3 strain was clustered into genotype III and was closely related to the contemporaneous DENV-3 strains from Laos, Vietnam, Thailand and India. Interestingly, seven Yunnan isolates (KR347359, KX262915, KJ438298, KR347397, KR347420, KX262916, KX262914), and nine strains from Laos (KF816148, KF816160, KF816162, LC147060, KF816158, KF816159, KF816161, LC147061, LC147059) that were identified in 2013, belonged to genotype II. Moreover, the phylogenetic tree based on CDS revealed that the YNPE3 strain was grouped into genotype III along with other DENV-3 isolates from different regions (Fig. [5](#Fig5){ref-type="fig"}). Phylogenetically, the strains Balotra87-s (KU216209), IND/58760 (JQ992556), DENV-3/IND/59826 (JQ992556) from India and two strains from China (JF504679, GU363549) were closely related to the YNPE3 strain. Interestingly, the YN01 and YN02 strains isolated in Yunnan in 2013 were classified into genotype II and were located in the same clades with seven strains isolated in Laos in 2010. Overall, the two trees suggested that the current strain belonged to the genotype III of DENV-3.Fig. 4Phylogenetic tree based on envelope gene of DENV-3 strains obtained by Maximum-Likelihood method in MEGA7.0. Black dot represents DENV-3 sequence isolated in current study, the Laos and other Chinese DENV-3 isolates are marked with black squares and triangles, respectively. A total of 76 reference strains of the five genotypes available in NCBI GenBank were used for comparison. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. The scale bar expresses the genetic distance. DENV strains are named as follows: GenBank accession number/strain/country/yearFig. 5Phylogenetic tree based on the complete coding sequences of DENV-3 strains obtained by Maximum-Likelihood method in MEGA7.0. Black dot represents DENV-3 sequence isolated in current study. The Laos and other Chinese DENV-3 isolates are marked with black squares and triangles, respectively. A total of 75 reference strains of the four genotypes available in NCBI GenBank are retrieved. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. The scale bar expresses the genetic distance. DENV strains are named as follows: GenBank accession number/strain/country/year

Discussion {#Sec13}
==========

Over recent years, dengue has become a serious public health concern in China. The imported cases of dengue from other countries, and especially Southeast Asia countries, have caused a regional epidemic in Yunnan, China \[[@CR26], [@CR27], [@CR37]\]. Therefore, disease surveillance and prevention employing genome sequencing and molecular and evolutionary studies of DENV isolates are of great importance. As stated in the introduction, dengue outbreak in Yunnan was related to the outbreak in Laos. In current research, the phylogenetic analysis based on E gene suggested that the YNPE3 strain was closely related to the contemporaneous strains isolated in Laos. Previous study has revealed a strong relationship between the Laos 2013 isolates genotype III and strains from Bhutan (2007) and India (2005) \[[@CR22]\]. Especially, the phylogenetic tree based on E gene indicated that strains from Thailand, Laos, Vietnam and Pakistan had a strong relationship with the India isolates of genotype III (from 2005 to 2013). The phylogenetic tree based on CDS also supported that YNPE3 strain had a close relationship with India isolates in 2005 (strains IND/58760 and DENV-3/IND/59826) and 2013 (strain Balotra87-s). These strains shared 98.2--98.9% nucleotide identity with YNPE3 strain. Nevertheless, the precise evolutionary relationship between strain YNPE3 and strains from Laos and India could not be confirmed due to lack of complete coding sequences information on genotype III from Laos during 2005--2013. Yet, previous studies have reported the emergence of genotype III from 2009 to 2011 in India and China \[[@CR38], [@CR39]\]. This genotype has re-emerged in Southeast Asian countries and it has been in circulation for a very long time. Moreover, the two phylogenetic trees indicated genotype II isolated in Yunnan was closely related with Laos strains isolated in 2010 and 2013, which suggested that this genotype most likely had common ancestor with the genotype II strains circulating in Laos.

Previous studies have indicated an important role of the secondary structure of the 5′ and 3′ UTR of the *Flaviviruses* in viral replication \[[@CR40], [@CR41]\], The deletion and insertion of bases in the 5′ and 3′ UTR probably leads to changes in RNA secondary structures. For most DENV isolates, the 3′ UTR of the genome contains three functional domains \[[@CR40], [@CR42]\]. The nucleotide insertions and mutations usually occur in domain I, which is close to the NS5 protein and is regarded as the variable region of the 3′ UTR of DENV-3 \[[@CR35], [@CR42]\], The potential effect of the insertion and mutation has shown to be related with viral replication efficiency \[[@CR36], [@CR43], [@CR44]\]. Our results revealed that the insertion of 11 nts occurred in domain I of the 3′ UTR of the YNPE3 strain, while the secondary structure of VR was different from that of strain H87, which was consistent with the results of a previous study \[[@CR45]\]. However, no significant change occurred in the whole secondary structure of 3′ UTR. The 5′ UTR has two domains, including the short stem loop domain II and large stem loop domain I, which are separated by a functional spacer oligo U sequence. Domain I is the promoter of the viral RNA-dependent RNA polymerase (RdRp). It comprises several conserved structures: three helix regions (Stem 1, Stem 2 and Stem 3), a top loop and a side stem loop \[[@CR35], [@CR46]\]. Most of the variations in sequence and structure occur in the side loop and Stem 3 helix region. The replication of the virus is affected if the side loop is deleted \[[@CR35], [@CR46]\]. Interestingly, the side loop and Stem 3 helix region of the YNPE3 strain were deleted. We further compared the differences in secondary structure of 5′ UTR and 3′ UTR between Yunnan strains YN01, YN02 and our strain YNPE3. The YN01 and YN02 revealed a same structure with H87 in 5′ UTR but a distinctive structure in 3′ UTR (data not show). Due to lack of a complete genome sequence of DENV-3 from Laos, no comparison could be made between YNPE3 and strains from Laos. Hence, further investigation is needed to elucidate the biological implication of these deletions and insertions.

As major viral antigen, the E protein can be recognized by host cells, thus inducing neutralizing antibodies and blocking membrane fusion and virion assembly \[[@CR47]--[@CR49]\]. Moreover, the virulence of dengue virus mainly depends on the E region. The mutations of amino acids in conserved regions of the E protein affect the viral attachment in host cells \[[@CR47]\]. The E~383:~ K(Lys) → N(Asn) and E~391~R(Arg) → K(Lys) might be related to the severity of the disease of DENV-3 \[[@CR50]\]. The mutations that occur in the E~124:~ S(Ser) → P(Pro), E~169:~ A(Ala) → T(Thr) and E~383:~ K(Lys) → N(Asn) are usually characteristics of genotype III \[[@CR51]\]. The E~169:~ A(Ala) → T(Thr) and E~301:~ L(Leu) → T(Thr) are two important non-conservative replacements that involve the nonpolar hydrophobic amino acid to polar amino acid. The E-169, as a positively selected site \[[@CR52]\], has been shown to be located in a murine B and T cell epitope \[[@CR53]\]. These mutations might be related to the transmission capacity of these isolates \[[@CR54]\]. Similar substitutions referring to shifts of polarity of amino acids were observed in other proteins, particularly in non-structural proteins NS1, NS2A, NS3 and NS5. Importantly, further studies are needed to confirm the actual functions of these substitutions. Like genotype III, genotype II strains from Laos and China also have exclusive amino acid substitution characteristics. We concluded that the same genotype, or the highly related strains shared some common characteristics in amino acid substitutions.

Conclusions {#Sec14}
===========

In conclusion, a full-length genome of an imported DENV-3 strain YNPE3 from Laos was reported for the first time. Deletions of nucleotides in the 3′ and 5′ UTR were observed. Studying the amino acid substitutions can lead to a better understanding of viral pathogenesis, which in turn might promote the development of new DENV vaccine. The genotype III and genotype II of DENV-3 from Yunnan were strongly related to those DENV-3 strains from Southeast Asia countries. Thus, the dengue surveillance and warning systems in Yunnan province of China need to be strengthened by timely monitoring of the two DENV-3 genotypes, that are prevalent in Southeast Asia.
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